Final oocyte maturation was triggered with GnRH agonist instead of hCG in two patients in the CD2 group and in eight patients in the CD4 group , because of an increased risk of ovarian hyperstimulation syndrome ( P = 0.078 , RR 3.7 ( 95 % CI 0.88-15 .8 ) .